Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURATE: TT-702 in Advanced Solid Tumours
NCT05272709Phase 2Recruiting
- Sponsor
- Cancer Research UK
- Start
- Jan 2022
- Primary completion
- Apr 2028
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TT-702 in solid tumor (advanced stage), sponsored by Cancer Research UK. Started Jan 2022; status: recruiting.
02
Drugs
TT-702
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05272709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05272709.